The discovery of antibiotics was one of the greatest milestones in modern medicine. Diseases that once claimed millions of lives became treatable, dramatically improving life expectancy worldwide. Antibiotics also laid the foundation for modern surgical procedures, organ transplantation, cancer chemotherapy, intensive care, and many other medical advances.

However, decades of widespread and sometimes inappropriate antibiotic use have contributed to one of today’s most pressing global health threats: antimicrobial resistance (AMR).

The World Health Organization (WHO) recognizes antimicrobial resistance as one of the top global public health challenges. Without responsible antibiotic use, common bacterial infections may become increasingly difficult—or even impossible—to treat.

For this reason, antibiotic stewardship and classification management have become essential strategies for preserving the effectiveness of antibiotics for future generations.

---

The Core Concept of Antibiotic Classification Management

Antibiotic classification management is a scientific system that guides the appropriate use of antimicrobial agents.

Healthcare institutions classify antibiotics according to factors such as:

• Antibacterial spectrum
• Risk of resistance
• Clinical effectiveness
• Safety profile
• Appropriate indications
• Cost-effectiveness

Different categories require different prescribing authority and approval procedures.

The principle is simple:

• Common bacterial infections should usually be treated with first-line antibiotics.
• Broad-spectrum or advanced antibiotics should be reserved for severe, complicated, or drug-resistant infections.

This approach is designed to ensure that every antibiotic is used:

• for the right patient,
• at the right time,
• with the right indication.

---

Why Is Antimicrobial Resistance Becoming Worse?

Bacteria constantly evolve.

When antibiotics are used inappropriately, susceptible bacteria die while resistant bacteria survive and multiply.

Over time, resistant strains become dominant.

Common causes include:

• Using antibiotics for viral illnesses such as colds or influenza
• Stopping antibiotics early after symptoms improve
• Self-medicating without medical advice
• Using broad-spectrum antibiotics unnecessarily
• Repeated inappropriate antibiotic exposure

These practices create selective pressure that accelerates resistance.

Eventually, infections that were once easily cured—including respiratory infections, urinary tract infections, skin infections, and postoperative infections—become increasingly difficult to treat.

Patients may require:

• longer hospitalization
• more toxic medications
• higher medical costs
• more complex treatment strategies

---

WHO AWaRe Classification

To support global antimicrobial stewardship, the WHO developed the AWaRe Classification System, which categorizes antibiotics into three groups.

Access

These antibiotics should be widely available and are recommended as first-line treatments for many common bacterial infections.

They generally have:

• lower resistance potential
• proven clinical effectiveness
• favorable safety profiles

---

Watch

Watch antibiotics carry a higher risk of promoting resistance.

They should only be prescribed when clearly indicated and require careful clinical assessment.

---

Reserve

Reserve antibiotics represent the final line of defense against multidrug-resistant bacteria.

These medicines should only be used for severe infections when alternative treatment options have failed.

Their effectiveness must be preserved whenever possible.

---

---

Why Classification Management Matters

Antibiotic stewardship provides benefits at multiple levels.

1. Slowing Resistance Development

Using appropriate first-line antibiotics whenever possible reduces unnecessary exposure to broad-spectrum agents and lowers selective pressure on bacteria.

---

2. Preserving Critical Antibiotics

Some antibiotics are among the few remaining treatment options for multidrug-resistant infections.

Restricting their use helps maintain their effectiveness for patients who truly need them.

---

3. Improving Precision Medicine

Successful infection treatment is not about choosing the strongest antibiotic.

It is about choosing the most appropriate antibiotic.

Clinical decision-making should incorporate:

• patient assessment
• microbiological testing
• bacterial culture
• antimicrobial susceptibility testing

This improves outcomes while reducing unnecessary adverse effects.

---

Benefits Beyond Individual Patients

Responsible antibiotic use benefits the entire healthcare system by:

• reducing antimicrobial resistance
• protecting limited medical resources
• lowering healthcare costs
• improving patient safety
• strengthening global public health preparedness

---

Everyone Has a Role

Healthcare professionals should:

• prescribe antibiotics appropriately
• avoid unnecessary broad-spectrum agents
• educate patients

Patients should:

• never self-medicate
• complete prescribed antibiotic courses
• avoid demanding antibiotics for viral illnesses
• never share leftover antibiotics

Responsible antibiotic use requires cooperation between clinicians, pharmacists, policymakers, and patients.

---

Looking Ahead

Antimicrobial resistance cannot be solved through education alone.

Future strategies will increasingly combine:

• antimicrobial stewardship programs
• rapid diagnostic technologies
• surveillance systems
• artificial intelligence
• precision infectious disease management
• international collaboration

Together, these efforts aim to preserve antibiotic effectiveness for generations to come.

---

Conclusion

Antibiotics transformed modern medicine, but their effectiveness is not unlimited.

Antibiotic stewardship and classification management help ensure that these life-saving medicines remain effective against bacterial infections.

Responsible prescribing, rational medication use, and global cooperation are essential to slowing antimicrobial resistance.

As a company committed to pharmaceutical innovation and responsible medication management, DengYue Pharma continues to monitor global developments in infectious diseases, antimicrobial stewardship, and clinical best practices.

Every responsible antibiotic prescription not only protects today’s patients—but also safeguards treatment options for future generations.